2025-09-01-UBS-Asia_Equity_Research_Quantitative_Research_Review_Winter-117336246页_67页_2mb

UBS Asia Equity Research: Quantitative Research Review Summary

Overview

This report, dated August 19, 2025, presents UBS's monthly quantitative assessment of stock analyst responses for companies in Asia. The review evaluates short-term factors through six key questions per company, focusing on industry structure, regulatory environment, historical performance, future earnings expectations, and potential catalysts. Responses, rated on a scale from 1 to 5 or binary (yes/no), provide forward-looking insights based on analysts' views as of July 2025.

Methodology

• Quantitative Analysis: The review quantifies analyst opinions, using numerical ratings for factors like industry improvement likelihood, regulatory risks, and earnings surprises.
• Questions Covered:
  1. Industry Momentum: Scale of 1-5 (1= declining, 5= improving).
  2. Regulatory Risk: Scale of 1-5 (1= worsening, 5= improving).
  3. Historical Performance: Scale of 1-5 (1= significantly worse, 5= significantly better).
     4 & 5. Future earnings surprises and risk skew (surprise vs. consensus), rated 1-5.
     6 & 7. Potential for short-term positive/negative catalysts (yes/no).
• Forward-Looking: All views are short-term, distinct from UBS's 12-month equity ratings. Data complements historical financial performance.

Key Findings from Company Responses

Based on 67 companies analyzed, the following trends emerge:

• Industry and Regulatory Views: Industries exhibit mixed outlooks, with many rating "no change" (rated 3). Regulatory environments are largely neutral, reflecting persistent challenges in some sectors but opportunities in others.
• Earnings Forecasts: Most companies rate positive/negative catalysts as "no". However, a minority indicate slight positive catalysts (e.g., AIA Group, Longi Green Energy Technology), signaling potential upside. Conversely, some (e.g., Air China, China Southern Airlines) face negative catalyst risks.
• Historical Performance: Performance is typically rated as "not much change" (rated 3), though some firms like Smoore International show improvement (rated 5/ish for historical), while others like Sichuan Swellfun see decline.
• Implied Valuations: Future earnings projections are moderate, with slight positive or negative surprises expected for some firms, and risks are often balanced, increasing opportunities for monitoring.

Risks and Disclaimer

• Conflicts of Interest: UBS prioritizing its business interests may affect objectivity. Readers are advised to use this report alongside fundamental research for investment decisions.
• Equity Rating Distinction: Views from the quantitative review are short-term and may differ from longer-term equity ratings. All views are independent of other reports unless specified.
• Access and Usage: UBS provides detailed disclosures on methodology, value risks, and ESG considerations on its website. Reusing or deep analysis for trading requires user discretion and compliance with regulations in respective jurisdictions.

Conclusion

The UBS Quantitative Research Review serves as a concise tool to gauge near-term market dynamics and corporate catalysts. It highlights both risks and opportunities, advocating due diligence to integrate with other research for informed investment strategies.